Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHFOTCHealthcare● Active
$2.34
+$0.00(+0.00%)
Market Cap$6.2B
P/E Ratio—
52W High$2.88
52W Low$2.14
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited（GZPHF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GZPHF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $75.45B | $74.99B | $75.52B | $70.79B | $69.01B |
| Cost of Revenue | $63.99B | $62.47B | $61.33B | $57.51B | $55.78B |
| Gross Profit | $11.46B | $12.52B | $14.19B | $13.28B | $13.23B |
| Gross Margin %(computed) | 15.18% | 16.70% | 18.79% | 18.76% | 19.17% |
| Operating Expenses | |||||
| R&D Expenses | $0.59B | $0.76B | $0.78B | $0.82B | $0.87B |
| G&A Expenses | $0.00B | $0.57B | $0.60B | $0.55B | $0.48B |
| Total Operating Expenses | $8.43B | $8.92B | $9.07B | $8.73B | $8.85B |
| Operating Income | $3.02B | $3.60B | $5.12B | $5.07B | $4.79B |
| Operating Margin %(computed) | 4.01% | 4.80% | 6.78% | 7.17% | 6.93% |
| Interest Income | $0.64B | $0.40B | $0.49B | $0.63B | $0.56B |
| Interest Expense | $0.42B | $0.42B | $0.47B | $0.43B | $0.42B |
| Income Before Tax | $3.59B | $3.61B | $5.11B | $5.04B | $4.72B |
| Income Tax Expense | $0.61B | $0.61B | $0.85B | $0.79B | $0.75B |
| Net Income | $2.91B | $2.84B | $4.06B | $3.97B | $3.72B |
| Net Margin %(computed) | 3.85% | 3.78% | 5.37% | 5.60% | 5.39% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.82 | $1.74 | $2.49 | $2.44 | $2.29 |
| Wtd Avg Shares | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B |
| EBITDA | $3.95B | $4.90B | $6.46B | $6.27B | $5.76B |
| EBITDA Margin %(computed) | 5.24% | 6.54% | 8.55% | 8.86% | 8.35% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CNY · B
深入了解Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
关于Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited（GZPHF）损益表
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited（GZPHF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，GZPHF实现营收$75.45B，毛利润$11.46B（毛利率15.18%），净利润$2.91B（净利率3.85%）。
常见问题
GZPHF · 4 问Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited（GZPHF）2025财年营收为$75.45B，同比up0.6%。
GZPHF revenueGZPHF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09